Mitogen-activated protein kinase (MAPK) phosphatase-1 and -4 attenuate p38 MAPK during dexamethasone-induced insulin resistance in 3T3-L1 adipocytes. [electronic resource]
- Molecular endocrinology (Baltimore, Md.) Jul 2004
- 1697-707 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0888-8809
10.1210/me.2003-0213 doi
3T3-L1 Cells--drug effects Adipocytes--drug effects Animals Arsenites--pharmacology Cell Cycle Proteins--drug effects Dexamethasone--pharmacology Dual Specificity Phosphatase 1 Dual-Specificity Phosphatases Enzyme Activation--drug effects Glucose--pharmacokinetics Glucose Transporter Type 4 Immediate-Early Proteins--drug effects Insulin Resistance Lentivirus--genetics Mice Mitogen-Activated Protein Kinase 3--drug effects Mitogen-Activated Protein Kinase Phosphatases Monosaccharide Transport Proteins--drug effects Muscle Proteins--drug effects Phosphatidylinositol 3-Kinases--drug effects Phosphoprotein Phosphatases--drug effects Protein Phosphatase 1 Protein Transport--drug effects Protein Tyrosine Phosphatases--drug effects Signal Transduction p38 Mitogen-Activated Protein Kinases--drug effects